Wikipedia

Besilesomab

Besilesomab
Monoclonal antibody
TypeWhole antibody
SourceMouse
TargetCEA-related antigen
Clinical data
Trade namesScintimun
License data
ATC code
  • none
Identifiers
CAS Number
ChemSpider
  • none
UNII
KEGG
(verify)

Besilesomab (trade name Scintimun) is a mouse monoclonal antibody labelled with the radioactive isotope technetium-99m. It is used to detect inflammatory lesions and metastases. It binds to an immunoglobulin, IgG1 isotype. SCINTIMUN has been used since 1992 mainly in Hungary, Czech Republic, and Switzerland on the basis of local marketing authorizations, and in Germany (on the basis of individual prescription). Between 1992 and 2009, an estimated 90,000 patients has been studied. In 2009, the EMEA has approved SCINTIMUN for marketing in all European countries.[1][2]

References

  1. ^ WHO Drug Information
  2. ^ Positive opinion of the CHMP for SCINTIMUN (Besilesomab) Archived December 25, 2009, at the Wayback Machine


This article is copied from an article on Wikipedia® - the free encyclopedia created and edited by its online user community. The text was not checked or edited by anyone on our staff. Although the vast majority of Wikipedia® encyclopedia articles provide accurate and timely information, please do not assume the accuracy of any particular article. This article is distributed under the terms of GNU Free Documentation License.

Copyright © 2003-2025 Farlex, Inc Disclaimer
All content on this website, including dictionary, thesaurus, literature, geography, and other reference data is for informational purposes only. This information should not be considered complete, up to date, and is not intended to be used in place of a visit, consultation, or advice of a legal, medical, or any other professional.